Cargando…

Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study

OBJECTIVES: To describe neurodevelopment at age 5 among children born preterm. DESIGN: Population based cohort study, EPIPAGE-2. SETTING: France, 2011. PARTICIPANTS: 4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, de...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierrat, Véronique, Marchand-Martin, Laetitia, Marret, Stéphane, Arnaud, Catherine, Benhammou, Valérie, Cambonie, Gilles, Debillon, Thierry, Dufourg, Marie-Noëlle, Gire, Catherine, Goffinet, François, Kaminski, Monique, Lapillonne, Alexandre, Morgan, Andrei Scott, Rozé, Jean-Christophe, Twilhaar, Sabrina, Charles, Marie-Aline, Ancel, Pierre-Yves, Langer, Bruno, Matis, Jacqueline, Kuhn, Pierre, Rebola, Muriel, Renesme, Laurent, Joly, Laurent, Lecomte, Benedicte, Datin-Dorriere, Valerie, Guillois, Bernard, Burguet, Antoine, Semama, Denis, Roué, Jean-Michel, Bretaudeau, Gilles, Rouget, Florence, Saliba, Elie, Favaris, Géraldine, Bednarek, Nathalie, Loron, Gauthier, Thiriez, Gerard, Chadie, Alexandra, de la Villéon, Gaëlle, Durrmeyer, Xavier, Granier, Michèle, Boileau, Pascal, Kayem, Gilles, Jarreau, Pierre-Henri, Foix-L’Hélias, Laurence, Boulot, Pierre, Daudé, Hubert, Bédu, Antoine, Mons, Fabienne, Deforge, Hélène, Fresson, Jeanne, Vayssière, Christophe, Breinig, Sophie, Truffert, Patrick, Nuytten, Alexandra, Charkaluk, Marie Laure, Brevaut, Veronique, Zahed, Meriem, Garcia, Patricia, Fayol, Laurence, Flamant, Cyril, Muller, Jean-Baptiste, Gascoin, Géraldine, Leke, André, Fontaine, Cécile, Claris, Olivier, Picaud, Jean-Charles, Ego, Anne, Patural, Hughes, Poulichet, Anne, Abrial, Aude, Favre, Anne, Fléchelles, Olivier, Ramful, Duksha, Carbonnier, Magali, Simeon, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080137/
https://www.ncbi.nlm.nih.gov/pubmed/33910920
http://dx.doi.org/10.1136/bmj.n741
_version_ 1783685366577889280
author Pierrat, Véronique
Marchand-Martin, Laetitia
Marret, Stéphane
Arnaud, Catherine
Benhammou, Valérie
Cambonie, Gilles
Debillon, Thierry
Dufourg, Marie-Noëlle
Gire, Catherine
Goffinet, François
Kaminski, Monique
Lapillonne, Alexandre
Morgan, Andrei Scott
Rozé, Jean-Christophe
Twilhaar, Sabrina
Charles, Marie-Aline
Ancel, Pierre-Yves
Langer, Bruno
Matis, Jacqueline
Kuhn, Pierre
Rebola, Muriel
Renesme, Laurent
Joly, Laurent
Lecomte, Benedicte
Datin-Dorriere, Valerie
Guillois, Bernard
Burguet, Antoine
Semama, Denis
Roué, Jean-Michel
Bretaudeau, Gilles
Rouget, Florence
Saliba, Elie
Favaris, Géraldine
Bednarek, Nathalie
Loron, Gauthier
Thiriez, Gerard
Chadie, Alexandra
de la Villéon, Gaëlle
Durrmeyer, Xavier
Granier, Michèle
Boileau, Pascal
Kayem, Gilles
Jarreau, Pierre-Henri
Foix-L’Hélias, Laurence
Boulot, Pierre
Daudé, Hubert
Bédu, Antoine
Mons, Fabienne
Deforge, Hélène
Fresson, Jeanne
Vayssière, Christophe
Breinig, Sophie
Truffert, Patrick
Nuytten, Alexandra
Charkaluk, Marie Laure
Brevaut, Veronique
Zahed, Meriem
Garcia, Patricia
Fayol, Laurence
Flamant, Cyril
Muller, Jean-Baptiste
Gascoin, Géraldine
Leke, André
Fontaine, Cécile
Claris, Olivier
Picaud, Jean-Charles
Ego, Anne
Patural, Hughes
Poulichet, Anne
Abrial, Aude
Favre, Anne
Fléchelles, Olivier
Ramful, Duksha
Carbonnier, Magali
Simeon, Thierry
author_facet Pierrat, Véronique
Marchand-Martin, Laetitia
Marret, Stéphane
Arnaud, Catherine
Benhammou, Valérie
Cambonie, Gilles
Debillon, Thierry
Dufourg, Marie-Noëlle
Gire, Catherine
Goffinet, François
Kaminski, Monique
Lapillonne, Alexandre
Morgan, Andrei Scott
Rozé, Jean-Christophe
Twilhaar, Sabrina
Charles, Marie-Aline
Ancel, Pierre-Yves
Langer, Bruno
Matis, Jacqueline
Kuhn, Pierre
Rebola, Muriel
Renesme, Laurent
Joly, Laurent
Lecomte, Benedicte
Datin-Dorriere, Valerie
Guillois, Bernard
Burguet, Antoine
Semama, Denis
Roué, Jean-Michel
Bretaudeau, Gilles
Rouget, Florence
Saliba, Elie
Favaris, Géraldine
Bednarek, Nathalie
Loron, Gauthier
Thiriez, Gerard
Chadie, Alexandra
de la Villéon, Gaëlle
Durrmeyer, Xavier
Granier, Michèle
Boileau, Pascal
Kayem, Gilles
Jarreau, Pierre-Henri
Foix-L’Hélias, Laurence
Boulot, Pierre
Daudé, Hubert
Bédu, Antoine
Mons, Fabienne
Deforge, Hélène
Fresson, Jeanne
Vayssière, Christophe
Breinig, Sophie
Truffert, Patrick
Nuytten, Alexandra
Charkaluk, Marie Laure
Brevaut, Veronique
Zahed, Meriem
Garcia, Patricia
Fayol, Laurence
Flamant, Cyril
Muller, Jean-Baptiste
Gascoin, Géraldine
Leke, André
Fontaine, Cécile
Claris, Olivier
Picaud, Jean-Charles
Ego, Anne
Patural, Hughes
Poulichet, Anne
Abrial, Aude
Favre, Anne
Fléchelles, Olivier
Ramful, Duksha
Carbonnier, Magali
Simeon, Thierry
author_sort Pierrat, Véronique
collection PubMed
description OBJECTIVES: To describe neurodevelopment at age 5 among children born preterm. DESIGN: Population based cohort study, EPIPAGE-2. SETTING: France, 2011. PARTICIPANTS: 4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, defined as severe/moderate cerebral palsy (Gross Motor Function Classification System (GMFCS) ≥2), or unilateral or bilateral blindness or deafness, or full scale intelligence quotient less than minus two standard deviations (Wechsler Preschool and Primary Scale of Intelligence, 4th edition). Mild neurodevelopmental disabilities, defined as mild cerebral palsy (GMFCS-1), or visual disability ≥3.2/10 and <5/10, or hearing loss <40 dB, or full scale intelligence quotient (minus two to minus one standard deviation) or developmental coordination disorders (Movement Assessment Battery for Children, 2nd edition, total score less than or equal to the fifth centile), or behavioural difficulties (strengths and difficulties questionnaire, total score greater than or equal to the 90th centile), school assistance (mainstream class with support or special school), complex developmental interventions, and parents’ concerns about development. The distributions of the scores in contemporary term born children were used as reference. Results are given after multiple imputation as percentages of outcome measures with exact binomial 95% confidence intervals. RESULTS: Among 4441 participants, 3083 (69.4%) children were assessed. Rates of severe/moderate neurodevelopmental disabilities were 28% (95% confidence interval 23.4% to 32.2%), 19% (16.8% to 20.7%), and 12% (9.2% to 14.0%) and of mild disabilities were 38.5% (33.7% to 43.4%), 36% (33.4% to 38.1%), and 34% (30.2% to 37.4%) at 24-26, 27-31, and 32-34 weeks, respectively. Assistance at school was used by 27% (22.9% to 31.7%), 14% (12.1% to 15.9%), and 7% (4.4% to 9.0%) of children at 24-26, 27-31, and 32-34 weeks, respectively. About half of the children born at 24-26 weeks (52% (46.4% to 57.3%)) received at least one developmental intervention which decreased to 26% (21.8% to 29.4%) for those born at 32-34 weeks. Behaviour was the concern most commonly reported by parents. Rates of neurodevelopment disabilities increased as gestational age decreased and were higher in families with low socioeconomic status. CONCLUSIONS: In this large cohort of children born preterm, rates of severe/moderate neurodevelopmental disabilities remained high in each gestational age group. Proportions of children receiving school assistance or complex developmental interventions might have a significant impact on educational and health organisations. Parental concerns about behaviour warrant attention.
format Online
Article
Text
id pubmed-8080137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80801372021-05-12 Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study Pierrat, Véronique Marchand-Martin, Laetitia Marret, Stéphane Arnaud, Catherine Benhammou, Valérie Cambonie, Gilles Debillon, Thierry Dufourg, Marie-Noëlle Gire, Catherine Goffinet, François Kaminski, Monique Lapillonne, Alexandre Morgan, Andrei Scott Rozé, Jean-Christophe Twilhaar, Sabrina Charles, Marie-Aline Ancel, Pierre-Yves Langer, Bruno Matis, Jacqueline Kuhn, Pierre Rebola, Muriel Renesme, Laurent Joly, Laurent Lecomte, Benedicte Datin-Dorriere, Valerie Guillois, Bernard Burguet, Antoine Semama, Denis Roué, Jean-Michel Bretaudeau, Gilles Rouget, Florence Saliba, Elie Favaris, Géraldine Bednarek, Nathalie Loron, Gauthier Thiriez, Gerard Chadie, Alexandra de la Villéon, Gaëlle Durrmeyer, Xavier Granier, Michèle Boileau, Pascal Kayem, Gilles Jarreau, Pierre-Henri Foix-L’Hélias, Laurence Boulot, Pierre Daudé, Hubert Bédu, Antoine Mons, Fabienne Deforge, Hélène Fresson, Jeanne Vayssière, Christophe Breinig, Sophie Truffert, Patrick Nuytten, Alexandra Charkaluk, Marie Laure Brevaut, Veronique Zahed, Meriem Garcia, Patricia Fayol, Laurence Flamant, Cyril Muller, Jean-Baptiste Gascoin, Géraldine Leke, André Fontaine, Cécile Claris, Olivier Picaud, Jean-Charles Ego, Anne Patural, Hughes Poulichet, Anne Abrial, Aude Favre, Anne Fléchelles, Olivier Ramful, Duksha Carbonnier, Magali Simeon, Thierry BMJ Research OBJECTIVES: To describe neurodevelopment at age 5 among children born preterm. DESIGN: Population based cohort study, EPIPAGE-2. SETTING: France, 2011. PARTICIPANTS: 4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, defined as severe/moderate cerebral palsy (Gross Motor Function Classification System (GMFCS) ≥2), or unilateral or bilateral blindness or deafness, or full scale intelligence quotient less than minus two standard deviations (Wechsler Preschool and Primary Scale of Intelligence, 4th edition). Mild neurodevelopmental disabilities, defined as mild cerebral palsy (GMFCS-1), or visual disability ≥3.2/10 and <5/10, or hearing loss <40 dB, or full scale intelligence quotient (minus two to minus one standard deviation) or developmental coordination disorders (Movement Assessment Battery for Children, 2nd edition, total score less than or equal to the fifth centile), or behavioural difficulties (strengths and difficulties questionnaire, total score greater than or equal to the 90th centile), school assistance (mainstream class with support or special school), complex developmental interventions, and parents’ concerns about development. The distributions of the scores in contemporary term born children were used as reference. Results are given after multiple imputation as percentages of outcome measures with exact binomial 95% confidence intervals. RESULTS: Among 4441 participants, 3083 (69.4%) children were assessed. Rates of severe/moderate neurodevelopmental disabilities were 28% (95% confidence interval 23.4% to 32.2%), 19% (16.8% to 20.7%), and 12% (9.2% to 14.0%) and of mild disabilities were 38.5% (33.7% to 43.4%), 36% (33.4% to 38.1%), and 34% (30.2% to 37.4%) at 24-26, 27-31, and 32-34 weeks, respectively. Assistance at school was used by 27% (22.9% to 31.7%), 14% (12.1% to 15.9%), and 7% (4.4% to 9.0%) of children at 24-26, 27-31, and 32-34 weeks, respectively. About half of the children born at 24-26 weeks (52% (46.4% to 57.3%)) received at least one developmental intervention which decreased to 26% (21.8% to 29.4%) for those born at 32-34 weeks. Behaviour was the concern most commonly reported by parents. Rates of neurodevelopment disabilities increased as gestational age decreased and were higher in families with low socioeconomic status. CONCLUSIONS: In this large cohort of children born preterm, rates of severe/moderate neurodevelopmental disabilities remained high in each gestational age group. Proportions of children receiving school assistance or complex developmental interventions might have a significant impact on educational and health organisations. Parental concerns about behaviour warrant attention. BMJ Publishing Group Ltd. 2021-04-28 /pmc/articles/PMC8080137/ /pubmed/33910920 http://dx.doi.org/10.1136/bmj.n741 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research
Pierrat, Véronique
Marchand-Martin, Laetitia
Marret, Stéphane
Arnaud, Catherine
Benhammou, Valérie
Cambonie, Gilles
Debillon, Thierry
Dufourg, Marie-Noëlle
Gire, Catherine
Goffinet, François
Kaminski, Monique
Lapillonne, Alexandre
Morgan, Andrei Scott
Rozé, Jean-Christophe
Twilhaar, Sabrina
Charles, Marie-Aline
Ancel, Pierre-Yves
Langer, Bruno
Matis, Jacqueline
Kuhn, Pierre
Rebola, Muriel
Renesme, Laurent
Joly, Laurent
Lecomte, Benedicte
Datin-Dorriere, Valerie
Guillois, Bernard
Burguet, Antoine
Semama, Denis
Roué, Jean-Michel
Bretaudeau, Gilles
Rouget, Florence
Saliba, Elie
Favaris, Géraldine
Bednarek, Nathalie
Loron, Gauthier
Thiriez, Gerard
Chadie, Alexandra
de la Villéon, Gaëlle
Durrmeyer, Xavier
Granier, Michèle
Boileau, Pascal
Kayem, Gilles
Jarreau, Pierre-Henri
Foix-L’Hélias, Laurence
Boulot, Pierre
Daudé, Hubert
Bédu, Antoine
Mons, Fabienne
Deforge, Hélène
Fresson, Jeanne
Vayssière, Christophe
Breinig, Sophie
Truffert, Patrick
Nuytten, Alexandra
Charkaluk, Marie Laure
Brevaut, Veronique
Zahed, Meriem
Garcia, Patricia
Fayol, Laurence
Flamant, Cyril
Muller, Jean-Baptiste
Gascoin, Géraldine
Leke, André
Fontaine, Cécile
Claris, Olivier
Picaud, Jean-Charles
Ego, Anne
Patural, Hughes
Poulichet, Anne
Abrial, Aude
Favre, Anne
Fléchelles, Olivier
Ramful, Duksha
Carbonnier, Magali
Simeon, Thierry
Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
title Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
title_full Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
title_fullStr Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
title_full_unstemmed Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
title_short Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study
title_sort neurodevelopmental outcomes at age 5 among children born preterm: epipage-2 cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080137/
https://www.ncbi.nlm.nih.gov/pubmed/33910920
http://dx.doi.org/10.1136/bmj.n741
work_keys_str_mv AT pierratveronique neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT marchandmartinlaetitia neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT marretstephane neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT arnaudcatherine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT benhammouvalerie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT camboniegilles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT debillonthierry neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT dufourgmarienoelle neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT girecatherine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT goffinetfrancois neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT kaminskimonique neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT lapillonnealexandre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT morganandreiscott neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT rozejeanchristophe neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT twilhaarsabrina neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT charlesmariealine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT ancelpierreyves neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT langerbruno neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT matisjacqueline neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT kuhnpierre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT rebolamuriel neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT renesmelaurent neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT jolylaurent neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT lecomtebenedicte neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT datindorrierevalerie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT guilloisbernard neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT burguetantoine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT semamadenis neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT rouejeanmichel neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT bretaudeaugilles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT rougetflorence neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT salibaelie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT favarisgeraldine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT bednareknathalie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT lorongauthier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT thiriezgerard neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT chadiealexandra neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT delavilleongaelle neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT durrmeyerxavier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT graniermichele neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT boileaupascal neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT kayemgilles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT jarreaupierrehenri neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT foixlheliaslaurence neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT boulotpierre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT daudehubert neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT beduantoine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT monsfabienne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT deforgehelene neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT fressonjeanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT vayssierechristophe neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT breinigsophie neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT truffertpatrick neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT nuyttenalexandra neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT charkalukmarielaure neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT brevautveronique neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT zahedmeriem neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT garciapatricia neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT fayollaurence neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT flamantcyril neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT mullerjeanbaptiste neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT gascoingeraldine neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT lekeandre neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT fontainececile neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT clarisolivier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT picaudjeancharles neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT egoanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT paturalhughes neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT poulichetanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT abrialaude neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT favreanne neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT flechellesolivier neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT ramfulduksha neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT carbonniermagali neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy
AT simeonthierry neurodevelopmentaloutcomesatage5amongchildrenbornpretermepipage2cohortstudy